The mazda pharma Guide 5th August to 11th August 2013 | Page 18
PHARMACEUTICAL EXPORT DECLINES
pharmaceutical exporters in India miserable. They are seeking some urgent short-term measures from the Union Government, if not any subsidies or funds. Several industry leaders and Pharmaceuticals Export Promotion Council of India (Pharmexcil) and others representing the exporters have already suggested short-term, medium-term and long term measures to revive the exports. They have even sought the intervention of the Commerce Ministry. The growth rate of pharmaceutical exports is expected to fall below 10 percent this year due to the slowdown in markets like North America and Europe. Going by the initial reports in the first quarter of the current financial year, the rate cannot go beyond nine per cent. The growth of Indian pharmaceutical exports during 2012-13 halved to 10.55 per cent over previous year to $14.6 billion. During 2011-12 the exports stood at $13.2 billion registering a growth of 23.7 per cent over 2010-11, according to the figures from the Pharmexcil. Moreover, Indian exporters have been facing additional pressure on account of increasing competition from China. India has been the leader in supplying paracetamol world-wide. In the first three months of the current year, Indian company has not won even one contract for global supply and Chinese companies have bagged the orders instead. India's pharmaceutical exports grew at less than half the pace it did last year, hurt by delays in drug approvals and products recalls in some of its key markets. In dollar terms, pharmaceutical exports rose 9.9% in fiscal 2013, compared with 23% a year earlier. But a weaker Indian currency — which fell about 18% over the last year meant that pharmaceutical exports grew 25% in rupee terms. This is the first time in the recent years that the Indian pharmaceutical exports saw single digit growth in dollar terms. Europe has faced recession with two countries Spai ??B?F?7VffW&??rF?R??7B?F?RV??FVB7FFW2?BWW&?R66?V?Bf?"?V&???b?b??F???&?W??'G2?Bw&?wF???W??'G2F?&?F?F?W6R&Vv???26r6?v??f?6?BFV6??R??&?W?6????rW?V7G2F?R6V7F?"F?w&?rBrRf?"F?R7W'&V?Bf?66??F?R6???W&6R???7G'??v??6??B6WBF&vWB?bC#V&??????'2?C?sS7&?&R?v?'F??bW??'G2'??&6?#B??26??gFVBF?RFVF??RF??&6?#b??&?6WWF?6?W??'G2g&??F?R6?V?G'?GW&??r#"?27F??BBCB?S?&??????'2s??S7&?&R??Wg&??C2?#b&??????'2c2?S7&?&R?F?R&Wf??W2?V"???7B??F???&?6WWF?6?6????W2vW&RffV7FVB'??7&?V6????2f7F?'2??R??v???FW&W7B&FW2?B??f?F??????vWfW"?F?R'WVRvV?V???rv??7B??7B???"v??&?7W'&V?6?W2?26??R2???"?V?F?F?R?WBW??'F??rf?&?2?v???RW??'G2F???'F??W&?6w&Wr2?CBRF?CB&??????&?WB'2#"?7&?&R??F??6RF?WW&?R&?6R?&v????F???0????vF?v???6??R?W??&?WG2??R??'F??W&?6?BWW&?R6?W?VBv?F???7&V6??r6??WF?F???g&??6?????F?R??FW&?F?????&?WG2&R????rF?R?fR?`??C"?c2&???????V"?v??W??'G2F???'F??W&?6?BWW&?R?Bw&?v?32R?B3R?&W7V7F?fV??6WfW&??&?6WWF?6???W'2????F??fRGG&?'WFVBF?R6??vF?v???w&?wF?F?FV??VB&?f?2g&??&VwV?F?'2?BG'Vr&V6??2?&?&???G"&VFG?w2?Bv?V??&?&R???rF?RF???F??6????W2F?B&V6??VBF?V?"&?GV7G2GW&??rF?R?7Bf?66?&V6W6R?bf&??W2?77VW2?&?&??&V6??VB?G2vV?W&?2??F?"?G"&VFG?w2?G2?F??FW&W76???G'Vr6?F??&??Bv?V??&?&V6??VB???FV?V?7B6?F?V?F&?WG2??&vR?6??F???&?6WWF?6?6????W2??RG"&VFG?w2?fRW&f?&?VBvV????F?RU2?&?WB?7Bf?66??B???&?r6????W2?fRv?fV?v??BwV?F?6R?b#Rf?"F?R7W'&V?Bf?66??F?R&?&?V???w&?wF??2??7F?&V??rf6VB'?F?R6????B?VF?V??&?6WWF?6?6????W2???F?v2???rF?W??'B?&?6WWF?6?&?GV7G2v?'F?U4BR?R&???????#"?2f?66???V??b&?V?BrW"6V?B6??&VBF?U4B2?#"&???????#?"?F?RU4B#R&?????F&vWB???vWfW"?f?"?&?W??'G2??#2?Bv?V?B&R6???V?v??rF6???f?Wr?bv??&?6??vF?v??F?R?&?6WWF?6??2W?&W76VB?G26??6W&?F?F?R???7G'?&?WBF?RV6????2??7G2???&?6WWF?6??&FW'2W7V6???g&??g&?6?B?V7BFWfV??VB6?V?G&?W2v?W&R?V?F?6??v?2?fR6??vVBF?v???Bv?V?B&R6???V?v??rF??VWBF?RU4B#R&?????W??'BF&vWBf?"#2?B?F?R??GW7G'?v2???6?F???F?6GW&R?F?W"V?W&v??r??'GV??F?W2?W7V6?????Vf7GW&??r?b&?fbFV?B"&?GV7G2?"&?GV7G2v?F?W??&VBFV?B?v??6?v?V?B?fg6WB6??R?bF?RFV7&V6W2???&FW'2?gW'F?W"?G&6??BG&6R&&6?FW2?2&VV???G&?GV6VB??6??6?v??V?G2W??'FVBF?F?Rv??&??&?WB2'B?bF?R??v???r&???F???2?BV?G?77W&?6W2?b$?FR????F?"&?GV7G2?F?RWW&?V??B?W&?6??&?WG266?V?FVBf?"SRW"6V?B?bF?R??F???&?6WWF?6?&?GV7BW??'G2?&Vf?V7F??rF?B??7B?bF?W6R&?GV7G2vW&R?FRF?F?R??v?W7B7V6?f?6F????bF?RU2f??B?BG'VrF???7G&F????U4dD??F?RW??'Bf??V?W2F?F?RWW&?V??BU2?&?WG27V?f??V?R&?WBF?R??v?V?G??b??F???&?6WWF?6?&?GV7G2?F?R??F???&?6WWF?6???GW7G'?&W?'FVB'W6??W72w&?wF??b&?WBRW"6V?B??6???V?FVBvw&VvFVBw&?wF?&FR&WGvVV?#b?r?B#?"??V?6Rf?"6??'B?FW&??F?Rv?fW&??V?B6??V?B??G&?GV6R6W'F???V7W&W2??R6??R&V&FW2?B7WG2??GWF?W2f?"F?RW??'FW'2?&W6?FW2F??2?&??6VBfV?GW&RgV?G2?Bf???6??76?7F?6R6?&R?V?6?VB2???r?FW&??V7W&W2????VF?FR&V?Vg2??F?Rf?&??bGWG?7WG2v?V?B??&?fRF?R??&?R?bF?RW??'FW'2????D?R??D?$?uT?DR?VwW7B#2RVwW7@???